of ESRD in a cohort of SLE patients to determine the relationship of ESRD with hospitalization.
The aim of this nationwide cohort study from Taiwan was to investigate the potential risk factors for ESRD and infectionrelated hospitalization in patients with newly diagnosed SLE.
M A T E R I A L S A N D M E T H O D S

Data sources
The National Health Insurance (NHI) program in Taiwan covers almost all the population at modest cost, and provides the data for research on issues related to cost, quality of services, medical practice patterns, accessibility to health care programs and treatment outcomes. This study used the medical claims data from 2000 to 2011 that were in the NHI Research Database (NHIRD). The NHIRD contains health care data on 99% of the insured population of Taiwan (approximately 23 million people) [7] . All information is encrypted to protect patient identity, and the encryption procedure was consistent between datasets, so that all claims belonging to each patient were linked. The confidentiality of the data follows the regulations of the Bureau of NHI. The Institutional Review Board (IRB) of Taipei City Hospital approved this study (IRB No.: TCHIRB-1020715-W), and waived the requirement for written consent.
Data collection
In Taiwan, SLE patients and ESRD patients requiring dialysis can receive catastrophic illness cards, exempting them from the cost-sharing required by the NHI program. SLE patients were defined as individuals who had catastrophic illness cards and a diagnosis of SLE defined by International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) code 710.0. Use of the NHI claims data led to the identification of 7368 subjects with new-onset SLE. Among these SLE patients, we identified individuals who received their first-ever ESRD certification during the period between 2000 and 2011, based on the longitudinal illness database of the NHI claims records. ESRD patients were defined as patients who had catastrophic illness cards and a diagnosis of ESRD defined by ICD-9-CM code 585. We excluded 42 subjects due to missing data on age and/or sex, or who had a diagnosis of ESRD preceding SLE. Thus, a total cohort of 7326 subjects was used for analysis.
Definition of infection-related hospitalization
We investigated all discharge diagnoses, and enrolled patients classified as having an infection-related hospitalization if any of the discharge diagnoses included an infection of interest, including bacteremia, pulmonary infections (e.g. viral pneumonia, bacterial pneumonia, influenza with respiratory manifestations and abscess of the lung), genitourinary infections (e.g. urinary tract infection, pyelonephritis and peri-nephric abscess) and soft tissue infections (e.g. cellulitis, necrotizing fascitis and gangrene). An infection-related hospitalization was defined as an event in which infection was a primary or secondary reason for hospitalization.
Other important independent variables
Juvenile-onset SLE was defined by diagnosis when <18 years old, adult-onset SLE by diagnosis between 18 and 50 years old, and late-onset SLE by diagnosis when >50 years old. The study cohort had 808 juvenile-onset cases, 5119 adult-onset cases and 1399 late-onset cases. The potential confounders included comorbid medical diseases, such as type 2 diabetes mellitus (ICD-9-CM code 250), hypertension (codes 401-405), coronary artery disease (CAD; code 410-414), congestive heart failure (CHF; code 428), hyperlipidemia (code 272) and chronic kidney disease (CKD; code 585). If these diagnostic codes were used in two or more ambulatory claims at 6 months before and after the index date, they were recorded as comorbidities. Pharmacologic treatment given at the diagnosis of SLE was also recorded.
Statistical analysis
We performed all analyses using the SAS System for Windows (version 9.3, SAS Institute Inc., Cary, NC, USA). The cohort data of SLE patients with and without infection-related hospitalizations were compared using the chi-square test for categorical variables. To examine whether patients with infection-related hospitalizations had a higher risk of developing ESRD, we computed the hazard ratios (HRs) and 95% confidence intervals (CIs) using a multivariate Cox proportional hazards model. In the stratified analyses, multivariate Cox proportional hazards models were run separately in different predefined subgroups, with segregation by age, sex, comorbidity and pharmacological treatment, to explore potential confounding of the relationship between infection-related hospitalization and ESRD. The HRs for SLE in these different subgroups were adjusted for other factors.
R E S U L T S
Characteristics of the cohort of SLE patients
The study cohort consisted of 7326 patients with SLE (88.7% female), and the mean follow-up time was 8.1 years (Table 1) . A total of 316 patients were diagnosed with ESRD during the study period, corresponding to an incidence of 4.3%. Approximately 17% of the patients had one hospitalization for infection, and 13.9% had two or more infection-related hospitalizations. SLE patients who had one or more infection-related hospitalizations had a higher mortality rate than those with no infection-related hospitalization (25.8% versus 8.5%, P < 0.001). A total of 241 patients died due to infection during hospitalization. ESRD developed in 35 of 303 (11.6%) patients with juvenile-onset SLE who had infection-related hospitalization(s), and in 7 of 505 (1.4%) patients with juvenile-onset SLE without infectionrelated hospitalization. During follow-up, 93.9% of all SLE patients received glucocorticoids, 85.5% received antimalarials and 54.9% received at least one immunosuppressant.
Risk for ESRD in patients with infection-related hospitalization
Multivariate analysis of patients with infection-related hospitalizations (n ¼ 2268) indicated that males had a higher risk for Thus, for patients with three or more infection-related hospitalizations, the HR for ESRD was 5.08 relative to patients with no infection-related hospitalizations (95% CI: 3.74-6.90).
When we grouped SLE patients by different causes of infection (septicemia/bacteremia, soft tissue infection and genitourinary infection), the septicemia/bacteremia group had the highest HR for ESRD relative to the non-infection group (HR 4.82; 95% CI: 3.40-6.85). The other risk factors in these three subgroups were similar to those for the overall group.
Risk for ESRD in patients with different numbers of infection-related hospitalizations
Multivariable analysis of groups with different numbers of infection-related hospitalizations (none, one, two, and three or more) indicated that the HR for ESRD in males and females increased as the number of hospitalizations increased (Table 3) . Analysis by age of SLE onset indicated that the risk for ESRD was highest for patients with juvenile-onset SLE and three or more hospitalizations (HR: 14.49; 95% CI: 6.72-28.86). We also performed multivariate stratified analyses of the risks for ESRD after adjusting for various comorbidities and medications. The initial results showed that patients with CKD were more likely to progress to ESRD. However, subgroup analysis indicated that patients with infection-related hospitalizations had significantly increased risk of ESRD after accounting for confounding by CKD. For patients without CKD, the HR was 8.35 (95% CI: 4.18-16.66) in those with three or more infection-related hospitalizations, compared with those with no hospitalization.
It is possible that the increased risk of infection may be associated with use of immunosuppressive agents to treat SLE. However, subgroup analysis showed that patients with infection-related hospitalizations had a higher risk of ESRD than patients without such conditions after accounting for confounding by use of immunosuppressive agents. It is also notable that patients with three or more infection-related hospitalizations but without hypertension had a greater risk for ESRD (HR: 7.57; 95% CI: 4.13-13.89) than those with no infectionrelated hospitalization and with hypertension. Thus, a patient with stable blood pressure still has a significantly greater risk of ESRD due to infection. We also analyzed the relationship of the number of infection-related hospitalizations with the risk of ESRD in patients with and without CKD ( Table 4) . Among patients with CKD, the prevalence rate of ESRD was 44% (n ¼ 184) in those with at least one infection-related hospitalization, but was 18.4% (n ¼ 68) in those with no infection-related hospitalization, a 2.4-fold increase. Among patients without CKD, the prevalence rate of ESRD was 2.1% (n ¼ 38) in those with at least one infection-related hospitalization, but was 0.5% (n ¼ 26) in those with no infection-related hospitalization, a 4.2-fold increase.
Cumulative incidence of ESRD in patients with infection-related hospitalizations
The ESRD cumulative incidence curves, after accounting for death and withdrawal from the database, show that patients with an increasing number of infection-related hospitalizations had an increasing risk of ESRD during the course of the observation period (Figure 1 ).
D I S C U S S I O N
Patients suffering from SLE have a greater risk of developing infections than the general population, and infection is the leading cause of mortality in these patients, followed by cardiovascular complications [5] . The present study is the first attempt to investigate the risk factors for ESRD in SLE patients from a nationwide cohort in Taiwan. The major results are that infection-related hospitalization is associated with a significantly increased risk of ESRD in patients with SLE, especially those with juvenile-onset SLE, and that among SLE patients admitted with an infectious disease, those with bacteremia were most likely to develop ESRD.
SLE patients who receive regular therapy and follow-up may have a reduced need for hospitalization. However, infection remains a significant complication, and is the most common reason for hospitalization [4] . We observed a high rate of infection-related hospitalization during our observation period (30.96%), and 44.9% of admitted patients had multiple admissions for infection. There were 241 deaths during hospitalization, and this accounted for 10.63% of all patients who were admitted for infections. Severe infectious disease is the major cause of morbidity and mortality in patients with SLE, and previous studies reported the prevalence of infection-related hospitalizations in these patients was 15.4-29% [8] [9] [10] . The higher rate of severe infection in our population may be due to our longer study period (mean follow-up of 8.1 years) and the high rate of insurance coverage by the NHI program in Taiwan.
The rate of infection-related hospitalization in our juvenileonset SLE patients was 37.5%, that of late-onset patients was 39% and that of adult-onset patients was 27.7%. This is consistent with a previous large cohort study in Taiwan, which reported that younger age was independently associated with development of ESRD among cases with newly diagnosed SLE [11] . The very young and very old SLE patients may be more predisposed to infections because hypocomplementemia and low concentrations of protective antibodies are more common in these groups. Several previous studies have examined the renal outcome of patients with SLE. Most of them focused on the association of disease activity, clinical symptomatic characteristics and laboratory findings with CKD, and the need for renal replacement therapy when the patient has progressed to ESRD [12] [13] [14] [15] . In this study, we further found that infectionrelated hospitalization in SLE patients increases the risk of renal damage, and that recurrent infections are more likely to lead to poor renal outcome and ESRD.
We also examined whether patients prone to infections had preceding underlying kidney disease, and were thus more likely to progress to ESRD. In this analysis, we compared patients with and without CKD, and estimated the risk of ESRD in patients with and without infection-related hospitalization. The results showed that the group with reduced renal function had increased risk of serious infection, but both groups had significantly increased risk of ESRD, regardless of renal involvement, if they were hospitalized for an infection. Moreover, our multivariate analysis showed that although CKD was a risk factor for ESRD, infection-related hospitalization was independently associated with ESRD following stratified analysis that adjusted for CKD and other confounding factors.
Several reports indicated that infection may lead to a deterioration of renal function. A serious bacterial infection can trigger host inflammatory responses and induce the production of acute phase reactants, such as C-reactive protein, and cytokines, such as interleukin-6, which can lead to decreased renal clearance [16] . In addition, tumor necrosis factor-a (TNF-a) plays an important role in sepsis, and increased levels can contribute to acute renal failure [17] . More specifically, increased production of TNF-a during inflammation may induce renal interstitial fibrosis, due to the increased levels of transforming growth factor-b1 and endothelin-1 [18] . Previous studies showed that increased levels of inflammation and pro-thrombotic markers were responsible for the deterioration of renal function [19, 20] .
Our study also showed that among SLE patients with infection-related hospitalization, the presence of comorbidities, including hypertension, CHF and CKD, significantly increased the risk of ESRD. These results are consistent with other studies, and emphasize that cardiovascular-related complications can affect renal outcome [21] [22] [23] . In recent times, there have been substantial improvements in the survival rates of patients with SLE due to an earlier diagnosis and appropriate use of immunosuppressive agents [24] . However, challenges remain in improving the long-term renal prognosis and quality-of-life of patients with SLE [25] .
Very few studies have examined the rates of infection-related hospitalization in an SLE cohort using a nationally representative sample. We used a nationwide hospitalization database from Taiwan and demonstrated that: (i) infection-related hospitalization is associated with a significantly increased risk of ESRD in SLE patients; (ii) young age and male sex increase the risk of ESRD; and (iii) cardiovascular disorders, including hypertension and CHF, also increase the risk of ESRD.
Patients with lupus nephritis generally have more severe disease and require augmentation of immunosuppressants, and this may increase the risk of infection and infection-related hospitalization. We used a multivariate analysis to determine if greater disease activity was a confounding factor that contributes to renal impairment in this population. The results show that prescription of immunosuppressants was not the sole reason for the poor renal survival of patients who were hospitalized for infection. This result suggests that, irrespective of lupus disease activity, which is associated with renal outcome, infections per se also increase the risk of developing ESRD in patients with SLE.
Our findings extend those of previous studies, in that we demonstrated an increased risk of developing ESRD when an SLE patient is hospitalized for infection. This suggests that clinicians should implement measures that reduce the incidence of serious infections in patients with SLE. In addition, a previous study reported that many SLE patients were hospitalized for avoidable conditions, such as pneumonia and cellulitis, which can often be managed by prompt and appropriate outpatient treatment [26] . Moreover, administration of vaccines against influenza and pneumococcus can prevent and limit infectious complications in patients with SLE [27] . The clinical implications of our results are that serious infection has a close relationship with ESRD, a major complication of SLE, and that implementation of measures that seek to reverse the trend of infectious complications in SLE are mandatory.
The major strengths of this work are that we used a nationwide population-based cohort of patients with newly diagnosed SLE from the NHIRD, and that we had a long mean follow-up. The main limitations are that we lacked detailed information on comorbidities, severity and extent of disease (including CKD stage), certain laboratory data (proteinuria, renal function, complements and autoantibodies) and data on clinical course and treatment (remission, relapse and treatment response). Patients who received short-term dialysis for acute renal failure, who died before enrollment in the database or who refused renal replacement therapy may not have been included in the NHIRD. However, because a diagnosis with ICD-9 codes 710.0 and 585 conveys consistent information for all patients, physicians generally accept the enrolled population as meeting standardized criteria without laboratory data on serum C3, C4, dsDNA, creatinine and estimated glomerular filtration rate.
In conclusion, patients with SLE experience high rates of hospitalization for infection, and this increases their risk for ESRD. Thus, clinicians must pay more attention to infectionrelated complications in SLE patients, because they have significant morbidity and mortality, and must also develop effective
